Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study
β Scribed by Majumdar, S. R.; Morin, S. N.; Lix, L. M.; Leslie, W. D.
- Book ID
- 120173586
- Publisher
- Springer-Verlag
- Year
- 2013
- Tongue
- English
- Weight
- 185 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Population-based epidemiological studies on osteoporosis are few. Our study evaluated the effects of menopause and certain putative behavioural risk factors on bone mineral density (BMD). Spinal and femoral neck BMD were measured with dual X-ray absorptiometry (DXA) from 1600 perimenopausal women ag
Bisphosphonates are the primary therapy for postmenopausal and glucocorticoid-induced osteoporosis. Case series suggest a potential link between prolonged use of bisphosphonates and low-energy fracture of subtrochanteric or diaphyseal femur as a consequence of oversuppression of bone resorption. Usi